These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9773551)

  • 41. [Sickle cell disease in heel injection screening. I].
    Peters M; Appel IM; Cnossen MH; Breuning-Boers JM; Heijboer H
    Ned Tijdschr Geneeskd; 2009 May; 153(18):854-7. PubMed ID: 19475863
    [No Abstract]   [Full Text] [Related]  

  • 42. [Neonatal screening for sickle cell anemia and other hemoglobinopathies in Martinique].
    Brunod M
    Med Trop (Mars); 1999; 59(4):412. PubMed ID: 10816758
    [No Abstract]   [Full Text] [Related]  

  • 43. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange].
    Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G
    Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Newborn screening follow-up within the lifespan context: Michigan's experience.
    Grigorescu V; Kleyn MJ; Korzeniewski SJ; Young WI; Whitten-Shurney W
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S522-7. PubMed ID: 20331953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prevalence of sickle cell anemia in Saudi children and adolescents. A community-based survey.
    Al-Mendalawi MD
    Saudi Med J; 2009 Mar; 30(3):452: author reply 452. PubMed ID: 19271087
    [No Abstract]   [Full Text] [Related]  

  • 46. The frequency of the sickle allele in Jamaica has not declined over the last 22 years.
    Hanchard NA; Hambleton I; Harding RM; McKenzie CA
    Br J Haematol; 2005 Sep; 130(6):939-42. PubMed ID: 16156863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy?
    Agasa B; Bosunga K; Opara A; Tshilumba K; Dupont E; Vertongen F; Cotton F; Gulbis B
    Transfus Med; 2010 Feb; 20(1):62-5. PubMed ID: 19712051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromatographic analysis of Hb S for the diagnosis of various sickle cell disorders in Pakistan.
    Hashmi NK; Moiz B; Nusrat M; Hashmi MR
    Ann Hematol; 2008 Aug; 87(8):639-45. PubMed ID: 18465131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut.
    Frempong T; Pearson HA
    Conn Med; 2007 Jan; 71(1):9-12. PubMed ID: 17288099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Family screening for HBB*S gene and detection of new cases of sickle cell trait in Northeastern Brazil].
    Bandeira FM; Santos MN; Bezerra MA; Gomes YM; Araujo AS; Braga MC; Souza WV; Abath FG
    Rev Saude Publica; 2008 Apr; 42(2):234-41. PubMed ID: 18327503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
    Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
    Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Newborn screening for sickle cell disease and other hemoglobinopathies. Survey of comprehensive centers for sickle cell disease.
    Scott RB
    Pediatrics; 1989 May; 83(5 Pt 2):908-9. PubMed ID: 2717329
    [No Abstract]   [Full Text] [Related]  

  • 55. Selective prophylactic transfusion in sickle cell disease.
    Grossetti E; Carles G; El Guindi W; Seve B; Montoya Y; Creveuil C; Dreyfus M
    Acta Obstet Gynecol Scand; 2009; 88(10):1090-4. PubMed ID: 19639465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction].
    Cela de Julián E; Dulín Iñiguez E; Guerrero Soler M; Arranz Leirado M; Galarón García P; Beléndez Bieler C; Bellón Cano JM; García Arias M; Cantalejo López A
    An Pediatr (Barc); 2007 Apr; 66(4):382-6. PubMed ID: 17430715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of pregnancy in homozygous sickle cell disease.
    Serjeant GR; Loy LL; Crowther M; Hambleton IR; Thame M
    Obstet Gynecol; 2004 Jun; 103(6):1278-85. PubMed ID: 15172865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal haemoglobinopathy screening in Burkina Faso.
    Kafando E; Nacoulma E; Ouattara Y; Ayéroué J; Cotton F; Sawadogo M; Gulbis B
    J Clin Pathol; 2009 Jan; 62(1):39-41. PubMed ID: 19103858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sickle cell disease in Africa: current situation and strategies for improving the quality and duration of survival].
    Diallo DA
    Bull Acad Natl Med; 2008 Oct; 192(7):1361-72; discussion 1372-3. PubMed ID: 19445362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.